# iPaxera vs DICOM Spectator

The clearest difference is review sentiment: iPaxera at 44% against DICOM Spectator's 0%. iPaxera also leads on rating (3.8 vs 1.0) and in-app purchases (none vs 1). On price, ads and device support there is nothing between them.

Both are free to download. DICOM Spectator sells 1 one-off in-app purchase. iPaxera asks for nothing beyond the download.

iPaxera holds the better App Store score, 3.8 against 1.0. That said, the two scores are not equally well evidenced: iPaxera has 8 ratings behind it against 1, so its average is the more settled of the two. Written reviews point the same way: 44% of iPaxera's written reviews are positive against 0% of DICOM Spectator's.

iPaxera ships an update every 3 months, DICOM Spectator every 80 months. The most recent releases landed on October 19, 2026 and October 8, 2026 respectively.

## The numbers

| Metric | iPaxera | DICOM Spectator |
| --- | --- | --- |
| Price | Free | Free |
| Rating | **[3.8 (8 ratings)](https://appshunter.io/ios/app/ipaxera/id432861550/reviews)** | [1.0 (1 ratings)](https://appshunter.io/ios/app/dicom-spectator/id1497425584/reviews) |
| Number of ratings | **8** | 1 |
| Positive reviews | **43.8% of reviews** | 0.0% of reviews |
| In-app purchases | **No** | Yes |
| Ads | No | No |
| Update frequency | **Every 3 months** | Every 80 months |
| Monetization | **Free** | Free with in-app purchases |
| Size | 31 MB | 76 MB |
| Requires iOS | **8.0** | 26.6 |
| Devices | **iPhone, iPad, iPod** | iPhone, iPad |
| Age rating | 4+ | 4+ |
| Developer | [PaxeraHealth Corp](https://appshunter.io/developer/432290457) | [Matthias Rudolph](https://appshunter.io/developer/597470203) |

## What reviewers say

### iPaxera

[App page](https://appshunter.io/ios/app/ipaxera/id432861550)

This medical imaging application allows healthcare professionals to view and navigate DICOM studies on their mobile devices. It supports local synchronization, reporting tools, and various image processing functions for efficient study analysis.

**Highlights:** DICOM study synchronization via iTunes, Embedded reporting tool with email export, Interactive image slider for navigation, Two-finger gestures for zoom, pan, and rotation, Single-finger drag for window width/level adjustment, Local study storage with search functionality

**Features:** macOS Compatibility

**In-app purchases:** none


### DICOM Spectator

[App page](https://appshunter.io/ios/app/dicom-spectator/id1497425584)

View and analyze medical images from DICOM files, including MRI, X-Ray, PET, and CT scans. Explore image sequences in 3D and manipulate them in real-time for detailed examination.

**Highlights:** View DICOM files, Supports MRI, X-Ray, PET, CT, 3D image visualization, Real-time image manipulation, Image sequence stacking

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases (1)**

| Purchase | Price | Billing |
| --- | --- | --- |
| Full Version | $4.99 | one-time |


## Frequently asked questions

### Is iPaxera free?

iPaxera is free to download, with no in-app purchases.

### Is DICOM Spectator free?

DICOM Spectator is free to download, with in-app purchases available.

### Which has better reviews, iPaxera or DICOM Spectator?

iPaxera is rated higher. iPaxera averages 3.8 out of 5 from 8 ratings, while DICOM Spectator averages 1.0 from 1 ratings.

### Do iPaxera or DICOM Spectator have ads?

Neither iPaxera nor DICOM Spectator shows ads.

### Which is updated more often, iPaxera or DICOM Spectator?

iPaxera ships an update every 3 months, and DICOM Spectator every 80 months. Most recently, iPaxera was updated on October 19, 2026 and DICOM Spectator on October 8, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*